Central Nervous System Cancers, Version 1.2015.

نویسندگان

  • Louis Burt Nabors
  • Jana Portnow
  • Mario Ammirati
  • Joachim Baehring
  • Henry Brem
  • Paul Brown
  • Nicholas Butowski
  • Marc C Chamberlain
  • Robert A Fenstermaker
  • Allan Friedman
  • Mark R Gilbert
  • Jona Hattangadi-Gluth
  • Matthias Holdhoff
  • Larry Junck
  • Thomas Kaley
  • Ronald Lawson
  • Jay S Loeffler
  • Mary P Lovely
  • Paul L Moots
  • Maciej M Mrugala
  • Herbert B Newton
  • Ian Parney
  • Jeffrey J Raizer
  • Lawrence Recht
  • Nicole Shonka
  • Dennis C Shrieve
  • Allen K Sills
  • Lode J Swinnen
  • David Tran
  • Nam Tran
  • Frank D Vrionis
  • Stephanie Weiss
  • Patrick Yung Wen
  • Nicole McMillian
  • Anita M Engh
چکیده

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Central Nervous System (CNS) Cancers provide interdisciplinary recommendations for managing adult CNS cancers. Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. These NCCN Guidelines Insights summarize the NCCN CNS Cancers Panel's discussion and highlight notable changes in the 2015 update. This article outlines the data and provides insight into panel decisions regarding adjuvant radiation and chemotherapy treatment options for high-risk newly diagnosed low-grade gliomas and glioblastomas. Additionally, it describes the panel's assessment of new data and the ongoing debate regarding the use of alternating electric field therapy for high-grade gliomas.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Role of Mammalian Target of Rapamycine Signaling Pathway in Central Nervous System Cancers: A Review

Mammalian mechanistic target of rapamycine (mTOR) is a conserved serine/threonine kinase in the cellular PI3K/Akt/mTOR signaling pathway. This pathway is modified by cellular alterations such as level of energy, growth factors, stresses, as well as the increased environmental level of cancerous cytokines. In general, increase of this kinase protein function is seen in various types of cancers, ...

متن کامل

P134: Central Nervous System and Blood Biomarker in Stroke, CNS Bleeding, Epilepsy, and Traumatic CNS Injury; MicroRNAs

A Central nervous system (CNS) hemorrhage is bleeding in or around the brain and spinal cord. Reasons of CNS hemorrhage include high blood pressure, cancers, drug abuse, abnormally weak blood vessels that leakage, and trauma. Regression of CNS bleeding was confirmed to be relatively repetitive in patients with severe FV, FX, FVII and FXIII deficiencies. Generally in CNS hemorrhage, radiological...

متن کامل

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

Background: Multiple sclerosis (MS), a central nervous system (CNS) autoimmune disorder, affects 2.3 million people around the world. Cancer kills around 7.5 million people annually. Both diseases have similar risks and intertwining molecular causes. Most studies focusing on MS and cancer have found an insignificant difference or reduction in the amount of cancer found in the MS community. M...

متن کامل

Review of the Aspergillosis and Report A Case of its Central Nervous System

SUMMARY Because Aspergillus SP. are one of the most common airborne fungal contaminants in all parts of the world, the incidence of Aspergillosis is relatively high, but will not be diagnosed in some cases. In this survey we decided to review the importance of Aspergillosis and also to report a case of its Central Nervous system involvement in a patient without Immunodeficiency.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of the National Comprehensive Cancer Network : JNCCN

دوره 13 10  شماره 

صفحات  -

تاریخ انتشار 2015